Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
One case study found that an infant with delayed development had slow gut motility along with other gastrointestinal symptoms, such as infrequent bowel movements, and was found to have low levels of carnitine
Retatrutide (also known by its development name LY3437943) is an investigational medication developed by Eli Lilly and Company
Final results may not be apparent for 6-12 months as swelling resolves and scars mature
Keep an eye on things like tiredness, changes in appetite, and your energy levels
You can message your provider, report your symptoms, and get guidance on whether to stay the course or adjust your dose immediately
US$ 27.94
US$ 24.34
US$ 29.07
US$ 24.23
US$ 27.04
